A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Cláudia M. Deus; Susana P. Pereira; Teresa Cunha-Oliveira; José A. Teixeira; Rui F. Simões; Fernando Cagide; Sofia Benfeito; Fernanda Borges; Nuno Raimundo; Paulo J. Oliveira

Journal title: Redox Biology, Vol 45, Iss , Pp 102037- (2021)

Journal number: 18

Journal publisher: Elsevier BV

Published year: 2021

DOI identifier: 10.1016/j.redox.2021.102037

ISSN: 2213-2317